Cargando...

Platelet inhibition with Ticlopidine in atherosclerotic intermittent claudication.

Fifty-one men with atherosclerotic intermittent claudication and haemorheological abnormalities completed a double-blind, one-year randomised trial of Ticlopidine (500 mg/day), a new antiplatelet agent. Ticlopidine caused significant inhibition of platelet aggregation but did not fully correct abnor...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Pathol
Autores principales: Aukland, A, Hurlow, R A, George, A J, Stuart, J
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Publishing Group 1982
Materias:
Acceso en línea:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC497768/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7047575/
https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jcp.35.7.740
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!